Isaac Francis

Coinbase is using Chainlink (CRYPTO:LINK) data feeds to provide market data for tokenised stocks on Base.

Symal Group (ASX:SYL) surpassed $1 billion in annual revenue for the first time, reporting $1.14 billion.

The United States is preparing to expand its economic sanctions against Iran, with the measures expected to target Iran's revenue streams and trade networks in an effort to intensify economic pressure on Tehran, according to a report by the New York Times.

REGENXBIO (NASDAQ:RGNX) reported that the U.S. Food and Drug Administration placed a clinical hold on its investigational MPS II gene therapy RGX-121 following spine MRI findings in five participants in the CAMPSIITE study.

Spruce Biosciences (NASDAQ:SPRB) announced that it completed two pre-BLA meetings with the U.S. Food and Drug Administration supporting its planned submission of a Biologics License Application for tralesinidase alfa enzyme replacement therapy in Sanfilippo Syndrome Type B.

Vanda Pharmaceuticals (NASDAQ:VNDA) announced that the European Commission granted orphan designation to imsidolimab for the treatment of generalized pustular psoriasis, following a positive opinion from the EMA Committee for Orphan Medicinal Products.

PDD Holdings (NASDAQ:PDD) reported Q2 2026 revenue of RMB112.4 billion (US$16.6 billion), up 8% year-over-year, supported mainly by higher transaction services revenue.

Ecovyst, ECVT stock, Laurie Bergman, CFO appointment, Michael Feehan, corporate leadership, executive changes, chemical industry

Takeda (NYSE:TAK) announced that Japan’s Ministry of Health, Labour and Welfare approved ORZEYFUL (oveporexton) for adults with narcolepsy type 1, making it the company’s third global approval for the treatment.

Banks and financial regulators across Europe, the Middle East and Asia have joined a quantum-resistant crypto pilot.